Palisade Bio (PALI) Share-based Compensation (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.29% |
| Dec 31, 2025 | 4,278.82% |
| Sep 30, 2025 | 41.67% |
| Jun 30, 2025 | 5.26% |
| Mar 31, 2025 | 112.95% |
| Dec 31, 2024 | -578.26% |
| Sep 30, 2024 | -26.40% |
| Jun 30, 2024 | 119.30% |
| Mar 31, 2024 | -90.59% |
| Dec 31, 2023 | 215.63% |
| Sep 30, 2023 | 33.33% |
| Jun 30, 2023 | 54.84% |
| Mar 31, 2023 | 8.14% |
| Dec 31, 2022 | -65.87% |
| Sep 30, 2022 | -25.00% |
| Jun 30, 2022 | -6.15% |
| Mar 31, 2022 | -47.58% |
| Dec 31, 2021 | 563.11% |
| Sep 30, 2021 | -79.19% |
| Jun 30, 2021 | -13.01% |
| Mar 31, 2021 | 21.06% |
| Dec 31, 2020 | -29.22% |
| Sep 30, 2020 | 68.96% |
| Jun 30, 2020 | 417.84% |
| Mar 31, 2020 | -36.46% |
| Dec 31, 2019 | -59.46% |
| Sep 30, 2019 | 128.77% |
| Jun 30, 2019 | -61.90% |
| Mar 31, 2019 | 429.65% |
| Dec 31, 2018 | -52.63% |
| Sep 30, 2018 | -31.54% |
| Jun 30, 2018 | -17.62% |
| Mar 31, 2018 | -10.15% |
| Dec 31, 2017 | -19.39% |
| Sep 30, 2017 | -49.42% |
| Jun 30, 2017 | 24.79% |
| Mar 31, 2017 | -9.73% |
| Dec 31, 2016 | -0.01% |
| Sep 30, 2016 | -29.16% |
| Jun 30, 2016 | -44.45% |
| Mar 31, 2016 | 77.15% |
| Dec 31, 2015 | 3.12% |
| Sep 30, 2015 | 28.64% |
| Jun 30, 2015 | -9.26% |
| Mar 31, 2015 | 1.29% |
| Dec 31, 2014 | 3.68% |
| Sep 30, 2014 | 21.43% |
| Jun 30, 2014 | -77.84% |
| Mar 31, 2014 | 873.82% |
| Dec 31, 2013 | -75.12% |
| Sep 30, 2013 | 68.87% |
| Jun 30, 2013 | 25.14% |
| Mar 31, 2013 | 12.66% |
| Dec 31, 2012 | -13.06% |
| Sep 30, 2012 | 47.17% |
| Jun 30, 2012 | -10.69% |
| Mar 31, 2012 | -19.22% |
| Dec 31, 2011 | -31.34% |
| Sep 30, 2011 | -36.92% |
| Jun 30, 2011 | -7.86% |
| Mar 31, 2011 | -11.52% |
| Dec 31, 2010 | -1.04% |